Consistently, GATA3 expression was higher in xenografts derived from breast cancer cells with shRNA NC compared with that in lncRNA LOC645166 - silencing group following treatment with adriamycin (Figure 5G). The gene discussed is GATA3; the disease is breast carcinoma.